Suppr超能文献

姜黄素负载杂化纳米粒子:基于微流控的制备及其在小鼠模型中的抗肿瘤活性。

Curcumin-Loaded Hybrid Nanoparticles: Microchannel-Based Preparation and Antitumor Activity in a Mouse Model.

机构信息

Department of Pharmacy, Taizhou Municipal Hospital, Taizhou, 318000, People's Republic of China.

College of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou, 310014, People's Republic of China.

出版信息

Int J Nanomedicine. 2021 Jun 17;16:4147-4159. doi: 10.2147/IJN.S303829. eCollection 2021.

Abstract

PURPOSE

To develop microchannel-based preparation of curcumin (Cur)-loaded hybrid nanoparticles using enzyme-targeted peptides and star-shaped polycyclic lipids as carriers, and to accomplish a desirable targeted drug delivery via these nanoparticles, which could improve the bioavailability and antitumor effects of Cur.

METHODS

The amphiphilic tri-chaintricarballylic acid-poly (ε-caprolactone)-methoxypolyethylene glycol (Tri-CL-mPEG) and the enzyme-targeted tetra-chain pentaerythritol-poly (ε-caprolactone)-polypeptide (PET-CL-P) were synthesized. The Cur-loaded enzyme-targeted hybrid nano-delivery systems (Cur-P-NPs) were prepared by using the microfluidic continuous granulation technology. The physicochemical properties, release behavior in vitro, and stability of these Cur-P-NPs were investigated. Their cytotoxicity, cellular uptake, anti-proliferative efficacy in vitro, biodistribution, and antitumor effects in vivo were also studied.

RESULTS

The particle size of the prepared Cur-P-NPs was 146.1 ± 1.940 nm, polydispersity index was 0.175 ± 0.014, zeta potential was 10.1 ± 0.300 mV, encapsulation rate was 74.66 ± 0.671%, and drug loading capacity was 5.38 ± 0.316%. The stability of Cur-P-NPs was adequate, and the in vitro release rate increased with the decrease of the environmental pH. Seven days post incubation, the cumulative release values of Cur were 52.78%, 67.39%, and 98.12% at pH 7.4, pH 6.8 and pH 5.0, respectively. Cur-P-NPs exhibited better cell entry and antiproliferation efficacy against U251 cells than the Cur-solution and Cur-NPs and were safe for use. Cur-P-NPs specifically targeted tumor tissues and inhibited their growth (78.63% tumor growth inhibition rate) with low toxic effects on normal tissues.

CONCLUSION

The enzyme-targeted hybrid nanoparticles prepared in the study clearly have the tumor-targeting ability. Cur-P-NPs can effectively improve the bioavailability of Cur and have potential applications in drug delivery and tumor management.

摘要

目的

开发基于微通道的姜黄素(Cur)负载杂化纳米粒子,使用酶靶向肽和星形多环脂质作为载体,并通过这些纳米粒子实现理想的靶向药物递送,从而提高 Cur 的生物利用度和抗肿瘤效果。

方法

合成两亲性三链三羧酸-聚(ε-己内酯)-甲氧基聚乙二醇(Tri-CL-mPEG)和酶靶向四链五赤藻糖醇-聚(ε-己内酯)-多肽(PET-CL-P)。采用微流控连续造粒技术制备载酶靶向杂化纳米递药系统(Cur-P-NPs)。考察了这些 Cur-P-NPs 的理化性质、体外释放行为和稳定性。还研究了它们的细胞毒性、细胞摄取、体外抗增殖作用、体内分布和体内抗肿瘤作用。

结果

制备的 Cur-P-NPs 的粒径为 146.1 ± 1.940nm,多分散指数为 0.175 ± 0.014,Zeta 电位为 10.1 ± 0.300mV,包封率为 74.66 ± 0.671%,载药量为 5.38 ± 0.316%。Cur-P-NPs 的稳定性足够,体外释放率随环境 pH 值的降低而增加。孵育 7 天后,在 pH7.4、pH6.8 和 pH5.0 下,Cur 的累积释放值分别为 52.78%、67.39%和 98.12%。Cur-P-NPs 对 U251 细胞的细胞进入和抗增殖作用优于 Cur 溶液和 Cur-NPs,且使用安全。Cur-P-NPs 对肿瘤组织具有特异性靶向能力,并抑制其生长(78.63%的肿瘤生长抑制率),对正常组织的毒性作用较低。

结论

研究中制备的酶靶向杂化纳米粒子具有明显的肿瘤靶向能力。Cur-P-NPs 可有效提高 Cur 的生物利用度,在药物递送和肿瘤管理方面具有潜在应用价值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3436/8216735/f63c10e86321/IJN-16-4147-g0001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验